Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

NovaBridge Biosciences (NBP) Revenue (2020 - 2023)

NovaBridge Biosciences (NBP) reported Revenue of $315000.0 for Q3 2023, up 98.11% on a QoQ basis from $159000.0 in Q2 2023.

NovaBridge Biosciences (NBP) has 3 years of Revenue data on file, last reported at $315000.0 in Q3 2023.

  • Quarterly Revenue changed N/A year-over-year to $315000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $2.0 million (changed N/A YoY) and the FY2023 annual result came in at $3.8 million, up 147.54% from the prior year.
  • Revenue advanced to $315000.0 in Q3 2023 per NBP's latest filing, from $159000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.5 million in Q4 2022 and bottomed at $40892.1 in Q4 2020.
  • The 3-year median for Revenue is $237000.0 (2023), against an average of $503723.0.

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 315,000.00
Jun 30, 2023 159,000.00
Dec 31, 2022 1.50 Mn
Dec 31, 2020 40,892.08